![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
NEUROPHARMACOLOGY
, and
Opioid Receptors
Department of Pharmacology, Joan and Sanford I. Weill Medical College of Cornell University, New York, New York (G.-M.Z., X.Q., H.H.S.); and Laboratory of Chemical Biology and Peptide Research, Clinical Research Institute of Montreal, Montreal, Quebec, Canada (P.W.S.).
[Dmt1]DALDA (H-Dmt-D-Arg-Phe-Lys-NH2; Dmt = 2',6'-dimethyltyrosine) binds with high affinity and selectivity to the µ opioid receptor and is a surprisingly potent and long-acting analgesic, especially after intrathecal administration. In an attempt to better understand the unique pharmacological profile of [Dmt1]DALDA, we have prepared [3H][Dmt1]DALDA and compared its binding properties with that of [3H]DAMGO ([D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin). Kinetic studies revealed rapid association of [3H][Dmt1]DALDA when incubated with mouse brain membranes (K+1 = 0.155 nM1 min1). Dissociation of [3H][Dmt1]DALDA was also rapid (K1 = 0.032 min1) and indicated binding to a single site. [3H][Dmt1]DALDA binds with very high affinity to human µ opioid receptor (hMOR) (Kd = 0.199 nM), and Kd and Bmax were reduced by sodium but not Gpp(NH)p [guanosine 5'-(
,
-imido)triphosphate]. Similar Kd values were obtained in brain and spinal cord tissues and SH-SY5Y cells. The hMOR:hDOR (human
opioid receptor) selectivity of [Dmt1]DALDA (
10,000) is 8-fold higher than DAMGO. However, [Dmt1]DALDA is less selective than DAMGO against hKOR (human
opioid receptor) (26-versus 180-fold). The Ki values for a number of opioid ligands were generally higher when determined by competitive displacement binding against [3H][Dmt1]DALDA compared with [3H]DAMGO, with the exception of Dmt1-substituted peptide analogs. All Dmt1 analogs showed much higher affinity for the µ receptor than corresponding Tyr1 analogs. [35S]GTP
S (guanosine 5'-O -(3-[35S]thio)triphosphate) binding showed that [Dmt1]DALDA and DAMGO are full agonists at hMOR and hDOR but are only partial agonists at hKOR. The very high affinity and selectivity of [3H][Dmt1]DALDA for the µ receptor, together with its very low nonspecific binding (1015%) and metabolic stability, make [3H][Dmt1]DALDA an ideal radioligand for labeling µ receptors.
Address correspondence to: Dr. Hazel H. Szeto, Department of Pharmacology, Weill Medical College of Cornell University, 1300 York Ave., New York, NY 10021. E-mail: hhszeto{at}med.cornell.edu
This article has been cited by other articles:
![]() |
D. A. Thomas, C. Stauffer, K. Zhao, H. Yang, V. K. Sharma, H. H. Szeto, and M. Suthanthiran Mitochondrial Targeting with Antioxidant Peptide SS-31 Prevents Mitochondrial Depolarization, Reduces Islet Cell Apoptosis, Increases Islet Cell Yield, and Improves Posttransplantation Function J. Am. Soc. Nephrol., January 1, 2007; 18(1): 213 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. N. Talbot, H. K. Happe, and L. C. Murrin {micro} Opioid Receptor Coupling to Gi/o Proteins Increases during Postnatal Development in Rat Brain J. Pharmacol. Exp. Ther., August 1, 2005; 314(2): 596 - 602. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Wang, X. Sun, L. M. Bohn, and W. Sadee Opioid Receptor Homo- and Heterodimerization in Living Cells by Quantitative Bioluminescence Resonance Energy Transfer Mol. Pharmacol., June 1, 2005; 67(6): 2173 - 2184. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Zhao, G.-M. Zhao, D. Wu, Y. Soong, A. V. Birk, P. W. Schiller, and H. H. Szeto Cell-permeable Peptide Antioxidants Targeted to Inner Mitochondrial Membrane inhibit Mitochondrial Swelling, Oxidative Cell Death, and Reperfusion Injury J. Biol. Chem., August 13, 2004; 279(33): 34682 - 34690. [Abstract] [Full Text] [PDF] |
||||